Your session is about to expire
← Back to Search
Comparative Control for Conduct Disorder
Study Summary
This trial aims to test a new virtual reality treatment called Impact VR to help reduce symptoms in 60 children with conduct disorder, which is a common psychiatric disorder in childhood.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has Experimental: Impact VR received approval from the FDA?
"Given the early stage of this trial, with limited supporting data for both safety and efficacy, our team at Power has assessed Experimental: Impact VR to be a 1 on the safety scale."
What are the eligibility criteria for individuals who can participate in this medical research study?
"Individuals aged between 10 and 17 years with a diagnosis of conduct disorder are eligible for enrolment in this clinical investigation, which has availability for up to 60 participants."
What is the aggregate count of individuals currently enrolled in this clinical investigation?
"The details on clinicaltrials.gov state that this medical trial is currently seeking participants. It was initially listed on February 16, 2024, and the most recent update occurred on March 3, 2024. The study aims to enroll 60 individuals at a single site."
Does this medical study include individuals aged 70 and older?
"To be eligible for this medical investigation, individuals aged between 10 and 17 years are sought after. Out of the total trials available, 14 are aimed at participants under 18 years old while only two cater to those over the age of 65."
Are participants currently being sought for enrollment in this ongoing medical study?
"Indeed, information available on clinicaltrials.gov highlights the ongoing recruitment status of this particular investigation. Originally shared with the public on February 16th, 2024, and most recently revised on March 3rd, 2024. The research is seeking to enroll a total of 60 patients from one designated site."
Share this study with friends
Copy Link
Messenger